Paratek Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.00
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.29
|
-0.38
|
-0.09
|
-31.03%
|
|
2022-06-30
|
-0.34
|
-0.33
|
0.01
|
2.94%
|
|
2022-03-31
|
-0.35
|
-0.35
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.41
|
-0.66
|
-0.25
|
-60.98%
|
|
2021-09-30
|
-0.45
|
-0.37
|
0.08
|
17.78%
|
|
2021-06-30
|
0.32
|
0.20
|
-0.12
|
-37.50%
|
|
2021-03-31
|
-0.38
|
-0.39
|
-0.01
|
-2.63%
|
|
2020-12-31
|
-0.04
|
-0.60
|
-0.56
|
-1400.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.06
|
|
2021-12-31
|
-1.22
|
|
2020-12-31
|
-2.25
|
|
2019-12-31
|
-3.93
|
|
2018-12-31
|
-3.57
|
|
2017-12-31
|
-3.35
|
|
2016-12-31
|
-5.67
|
|
2015-12-31
|
-10.38
|
|
2013-12-31
|
-15.60
|
|
2012-12-31
|
-9.24
|
|
2011-12-31
|
-3.72
|
|
2010-12-31
|
-8.40
|
|
2009-12-31
|
-23.50
|
|
2008-12-31
|
-179.95
|
|
2007-12-31
|
-16.56
|
|
2006-12-31
|
-14.88
|